Form 8-K - Current report:
SEC Accession No. 0001789769-21-000018
Filing Date
2021-04-27
Accepted
2021-04-27 17:23:32
Documents
2
Period of Report
2021-04-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K instilbio-8xkxitem80142721.htm 8-K 31115
2 EX-99.1 pr-instilbioxorphandrug202.htm EX-99.1 9677
  Complete submission text file 0001789769-21-000018.txt   41815
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 21860164
SIC: 2836 Biological Products, (No Diagnostic Substances)